183 related articles for article (PubMed ID: 3285750)
1. High-cost life prolongation: the National Kidney Dialysis and Kidney Transplantation Study.
Gutman RA
Ann Intern Med; 1988 Jun; 108(6):898-9. PubMed ID: 3285750
[No Abstract] [Full Text] [Related]
2. Limited resources and the treatment of end-stage renal failure in Britain and the United States.
Rennie D; Rettig RA; Wing AJ
Q J Med; 1985 Jul; 56(219):321-36. PubMed ID: 3912791
[No Abstract] [Full Text] [Related]
3. The American health care system. The End Stage Renal Disease Program.
Iglehart JK
N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
[No Abstract] [Full Text] [Related]
4. Dialysis and transplant.
Waterfall WK
Br Med J; 1980 Sep; 281(6242):726-7. PubMed ID: 7000276
[No Abstract] [Full Text] [Related]
5. Justice and cost-containment in end-stage renal disease.
Johnstone BV
J Contemp Health Law Policy; 1987; 3():65-84. PubMed ID: 10301637
[No Abstract] [Full Text] [Related]
6. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
Wikström B; Fored M; Eichleay MA; Jacobson SH
Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
[TBL] [Abstract][Full Text] [Related]
7. Rationing of health care and the end-stage renal disease program.
Klahr S
Am J Kidney Dis; 1990 Oct; 16(4):392-5. PubMed ID: 2220792
[TBL] [Abstract][Full Text] [Related]
8. The organization and financing of end-stage renal disease in Spain.
Luño J
Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
[TBL] [Abstract][Full Text] [Related]
9. The organization and financing of dialysis and kidney transplantation services in New Zealand.
Ashton T; Marshall MR
Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
[TBL] [Abstract][Full Text] [Related]
10. Kidneys, ethics, and politics: policy lessons of the ESRD experience.
Caplan AL
J Health Polit Policy Law; 1981; 6(3):488-503. PubMed ID: 7033349
[TBL] [Abstract][Full Text] [Related]
11. International Study of Health Care Organization and Financing of renal services in England and Wales.
Nicholson T; Roderick P
Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
[TBL] [Abstract][Full Text] [Related]
12. Nephrology and the rationing of health care.
Friedman EA
Contrib Nephrol; 1993; 102():220-36. PubMed ID: 8416184
[No Abstract] [Full Text] [Related]
13. Provider-patient relations and treatment choice in the era of fiscal incentives: the case of the end-stage renal disease program.
Bovbjerg RR; Held PJ; Diamond LH
Milbank Q; 1987; 65(2):177-202. PubMed ID: 3614141
[TBL] [Abstract][Full Text] [Related]
14. End-stage renal disease therapy: an American success story.
Friedman EA
JAMA; 1996 Apr; 275(14):1118-22. PubMed ID: 8601932
[No Abstract] [Full Text] [Related]
15. [Controversies in nephrology: dialysis in the elderly].
Ortega F; Gómez E; Baltar J; Rebollo P
Nefrologia; 2001; 21(4):332-6. PubMed ID: 11816505
[No Abstract] [Full Text] [Related]
16. Socioeconomic impact of the end-stage renal disease program in the USA.
Novello AC; Topper HP
Contrib Nephrol; 1989; 71():158-63. PubMed ID: 2805694
[No Abstract] [Full Text] [Related]
17. Life and death in a welfare state: end-stage renal disease in the United Kingdom.
Halper T
Milbank Mem Fund Q Health Soc; 1985; 63(1):52-93. PubMed ID: 3923389
[TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness analysis of treatment for end-stage renal disease].
Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
[TBL] [Abstract][Full Text] [Related]
19. [Financial incentives and dialysis].
Keller F; Dress H; Mertz A; Marckmann G
Med Klin (Munich); 2007 Aug; 102(8):659-64. PubMed ID: 17694285
[TBL] [Abstract][Full Text] [Related]
20. The management of end-stage renal disease in underdeveloped countries: a moral and an economic problem.
Saieh-Andonie C
Pediatr Nephrol; 1990 Mar; 4(2):199-201. PubMed ID: 2397189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
